Clinical Trials and Studies
Blood Disorders and Hematologic Cancers
- A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
- A Study for Patients with Large B-Cell Lymphoma Who have Completed Initial Therapy
- Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease Treatment Study
- Cold Agglutinin Disease Real World Evidence Registry
- Drug Treatment Study for Children with Hemophilia A
- Evaluation of Pediatric Palliative Inpatient Process
- Expanded Access Protocol (EAP) for Subjects Receiving Lisocabtagene Maraleucel
- Health Literacy and Numeracy in Adolescent Patients with Hemophilia A and B Study
- Hemophilia A or B Treatment Study
- Hemophilia A Treatment Study
- Luspatercept versus Placebo in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis
- Mastocytosis Patient Registry
- Molecular and Clinical Biology of von Willebrand Disease Study
- National Registry of All Persons with Bleeding and Clotting Disorders
- Newly Diagnosed T-Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma Treatment Study
- Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
- Study for Patients with Acute Myelogenous Leukemia
- Study for Patients with Multiple Myeloma
- Study for Subjects with Multiple Myeloma
- Study of Biomarkers in Hemophilic Arthropathy
- Study of Hepatitis C Virus Outcomes After Treatment in Patients with Bleeding Disorders
- Study Treating Patients With High-Risk Smoldering Myeloma
- Treatment Option for Relapsed or Refractory Multiple Myeloma
- Treatment Study for Children with Hemophilia B
- Treatment Study for Newly Diagnosed High Risk B-Lymphoblastic Leukemia in Patients with Ph-like TKI Sensitive Mutations
- Treatment Study for Patients with Localized Central Nervous System Germ Cell Tumors
- Treatment Study for Patients with Newly Diagnosed B-Lymphoblastic Leukemia or B-Lineage Lymphoblastic Lymphoma
- Treatment Study for Pediatric Patients with Hemophilia A
- Treatment Study for Subjects with Severe Hemophilia A or B
- Treatment Study for Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Breast Cancer
- A Phase I Study to Evaluate the Safety of Intratumoral Influenza Vaccine Administration in Patients with Breast Cancer
- De-Escalation of Breast Radiation Trial (DEBRA)
- E-Mindfulness Approaches for Living After Breast Cancer (HEAL-ABC)
- ELEGANT/STML-ELA-0422 Study for Breast Cancer Patients
- Estrogen Receptor Status Study
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
- NSABP B-63/ASCENT-05/GS-US-595-6184
- NSABP B-64/ EXActDNA-003 Breast Cancer Clinical Validation Study
- Scalp Cooling for Breast and Ovarian Cancer Patients
- Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer (SCARLET)
- Study for Patients with Metastatic Solid Tumors and Metastatic Breast Cancer
- Study of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)
Gastrointestinal Cancers
- Act Fast Study for Patients with Colorectal Cancer or Colorectal Lesion
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
- Initial Feasibility Study to Treat Pancreatic Cancer With a Planar LDR Source
- Pancreatic Cancer Screening Study
- Refractory Small Bowel Adenocarcinoma Treatment Study
- Retrospective Chart Review of Patients with Fibrolamellar Carcinoma
- Study of Eating Patterns and Alcohol Consumption in Patients with Advanced Tubular Adenoma
Genitourinary Cancers
- Chemoradiotherapy Study for Patients with Localized Muscle Invasive Bladder Cancer
- EA8191: INDICATE
- NRG-GU014: Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Prostate Cancer Study
- Prostate Cancer: De-Intensification and Intensification Clinical Trial
- Study of Standard Systemic Therapy in Treating Prostate Cancer
- The ICONIC Trial for Rare Genitourinary Cancers
- The PROBE Trial: Treatment Study for Metastatic Kidney Cancer
- The RadiCaL Study: Testing the Addition of a New Anti-Cancer Drug to the Usual Treatment for Advanced Renal Cell Cancer that has Spread to the Bone
- Treating Participants With Metastatic Prostate Cancer
- Treating Patients With High Risk Prostate Cancer
- Treatment Study for Patients With Muscle-Invasive Bladder Cancer
- Treatment Study for Rare Genitourinary Cancers
Gynecologic Cancers
Head and Neck Cancer
- Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer Treatment Study
- Testing Immunotherapy Versus Observation in Patients with HPV Throat Cancer
- Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
- The MCLA-158-CL02 Study for Patients with Head and Neck Cancer
- Treatment Study for Squamous Cell Carcinoma of the Head and Neck
Pediatric Cancers and Blood Disorders
- Childhood B-Lymphoblastic Leukemia Treatment Study
- Hepatoblastoma Treatment Study
- Newly Diagnosed Classical Hodgkin Lymphoma Treatment Study
- Retrospective Chart Review of Patients with Fibrolamellar Carcinoma
- Study of Transient Myeloproliferative Disorder in Children with Down Syndrome
- Treatment Study for Patients with Acute Myeloid Leukemia
- Treatment Study for Patients with Anaplastic Large Cell Lymphoma
- Treatment Study of Non-Metastatic Desmoplastic Medulloblastoma in Children